Christopher McCrae

954 total citations · 2 hit papers
38 papers, 498 citations indexed

About

Christopher McCrae is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Christopher McCrae has authored 38 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 14 papers in Immunology. Recurrent topics in Christopher McCrae's work include Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory viral infections research (9 papers). Christopher McCrae is often cited by papers focused on Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory viral infections research (9 papers). Christopher McCrae collaborates with scholars based in United Kingdom, Sweden and United States. Christopher McCrae's co-authors include Per Gustafson, Maria Gerhardsson de Verdier, Staffan Edsbäcker, Dave Singh, Neil Johnston, Maria Jison, William W. Busse, Michael D. Evans, Yury A. Bochkov and Rebecca Brockman‐Schneider and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

Christopher McCrae

37 papers receiving 493 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

2024 69 citations Michael E. Wechsler, Parameswaran Nair et al. New England Journal of Medicine profile →
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis

2024 34 citations Marc E. Rothenberg, Evan S. Dellon et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher McCrae United Kingdom	13	211	163	127	91	79	38	498
Deyun Cheng China	13	232 1.1×	144 0.9×	80 0.6×	48 0.5×	40 0.5×	33	437
Atsushi Moriwaki Japan	15	178 0.8×	217 1.3×	173 1.4×	50 0.5×	17 0.2×	31	464
Takehiro Hasegawa Japan	10	118 0.6×	80 0.5×	61 0.5×	55 0.6×	20 0.3×	24	369
Barbara Dierdorp Netherlands	9	111 0.5×	223 1.4×	167 1.3×	65 0.7×	63 0.8×	15	422
Masachika Hayashi Japan	10	116 0.5×	79 0.5×	59 0.5×	102 1.1×	37 0.5×	34	269
Eirini Neofytou Greece	12	211 1.0×	78 0.5×	78 0.6×	77 0.8×	41 0.5×	24	441
Heng Chhay United States	5	91 0.4×	207 1.3×	91 0.7×	25 0.3×	40 0.5×	7	370
Osamu Sakito Japan	5	272 1.3×	126 0.8×	95 0.7×	141 1.5×	37 0.5×	13	445
Hiroshige Oda Japan	6	237 1.1×	116 0.7×	83 0.7×	127 1.4×	33 0.4×	11	422
Hideki Kusagaya Japan	9	197 0.9×	115 0.7×	74 0.6×	33 0.4×	79 1.0×	21	362

Countries citing papers authored by Christopher McCrae

Since Specialization

Citations

This map shows the geographic impact of Christopher McCrae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McCrae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McCrae more than expected).

Fields of papers citing papers by Christopher McCrae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher McCrae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McCrae. The network helps show where Christopher McCrae may publish in the future.

Co-authorship network of co-authors of Christopher McCrae

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher McCrae. A scholar is included among the top collaborators of Christopher McCrae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher McCrae. Christopher McCrae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCrae, Christopher, et al.. (2025). Pharmacodynamic Effects of Benralizumab on Eosinophil-related Biomarkers in COPD: A Biomarker Analysis of the GALATHEA Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A4065–A4065. 1 indexed citations

Malmhäll, Carina, Jenny Calvén, Julie Weidner, et al.. (2025). Sex disparity in adult asthma—A potential immunomodulatory role of let‐7 family microRNAs. Clinical and Translational Allergy. 15(3). e70042–e70042. 2 indexed citations

Hellmich, Bernhard, Arnaud Bourdin, David Jayne, et al.. (2025). The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis. Arthritis & Rheumatology. 78(3). 695–704.

Staples, Karl J., B. Angermann, Graham Belfield, et al.. (2025). Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD. Respiratory Research. 26(1). 114–114. 1 indexed citations

Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2024). Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. New England Journal of Medicine. 390(24). 2252–2263. 34 indexed citations breakdown →

Wechsler, Michael E., Parameswaran Nair, Benjamin Terrier, et al.. (2024). Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. New England Journal of Medicine. 390(10). 911–921. 69 indexed citations breakdown →

Wechsler, Michael E., David J. Jackson, Ulrich Specks, et al.. (2024). The Effect of Benralizumab Versus Mepolizumab on the Depletion of Eosinophils in the Treatment of Eosinophilic Granulomatosis With Polyangiitis During the Phase 3 MANDARA Study. A5364–A5364. 1 indexed citations

Haldar, Koirobi, Vijay Mistry, Maria Jison, et al.. (2024). Effect of benralizumab treatment on the airway microbiome in COPD. ERJ Open Research. 11(2). 802–2024. 2 indexed citations

Åstrand, Annika, Johan Mattsson, Komal Agrawal, et al.. (2024). A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors. PLoS ONE. 19(5). e0301845–e0301845. 2 indexed citations

10.

Rothenberg, Marc E., Evan S. Dellon, Margaret H. Collins, et al.. (2023). 610 EFFICACY AND SAFETY OF BENRALIZUMAB IN ADULTS AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 24-WEEK DOUBLE-BLIND PERIOD OF THE PHASE 3 MESSINA TRIAL. Gastroenterology. 164(6). S–114. 8 indexed citations

11.

Todd, Jamie L., Jeremy M. Weber, Francine L. Kelly, et al.. (2023). BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk. CHEST Journal. 164(3). 670–681. 7 indexed citations

12.

Southworth, Thomas, Zala Jevnikar, Christopher McCrae, & Dave Singh. (2022). A Sputum 6-Gene Signature Predicts Airway Inflammation Endotypes and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease. Biomarkers in Medicine. 16(4). 277–289. 2 indexed citations

13.

Watson, Alastair, Christopher McCrae, Doriana Cellura, et al.. (2019). Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies. American Journal of Respiratory and Critical Care Medicine. 201(1). 83–94. 55 indexed citations

14.

Fleming, John, Joy Conway, Michael J. Bennett, et al.. (2019). Quantitative Assessment of Mucociliary Clearance in Smokers with Mild-to-Moderate Chronic Obstructive Pulmonary Disease and Chronic Bronchitis from Planar Radionuclide Imaging Using the Change in Penetration Index. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(4). 175–188. 2 indexed citations

15.

McCrae, Christopher, Marcus Ståhlman, Nicola Williams, et al.. (2018). Lanosterol Synthase Regulates Human Rhinovirus Replication in Human Bronchial Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 59(6). 713–722. 9 indexed citations

16.

Arike, Liisa, Ana M. Rodríguez‐Piñeiro, Beatriz Martínez‐Abad, et al.. (2018). Attached stratified mucus separates bacteria from the epithelial cells in COPD lungs. JCI Insight. 3(17). 37 indexed citations

17.

Johnston, Neil, Marita Olsson, Staffan Edsbäcker, et al.. (2017). Colds as predictors of the onset and severity of COPD exacerbations. International Journal of COPD. Volume 12. 839–848. 13 indexed citations

18.

Marshall, Jason D., Darren Heeke, David C. Hornigold, et al.. (2016). A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation. PLoS ONE. 11(10). e0164632–e0164632. 14 indexed citations

19.

Wenlock, Mark C., et al.. (2012). Selection of a screening panel of rhinoviral serotypes. Bioorganic & Medicinal Chemistry Letters. 22(24). 7494–7498. 1 indexed citations

20.

Jenkinson, Lesley, et al.. (2011). Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds. Journal of Virological Methods. 173(2). 182–188. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact